Arterial angioplasty – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Sat, 20 Jun 2026 04:04:21 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Arterial angioplasty – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 A study comparing one month versus one year of aspirin and clopidogrel treatment in patients with chronic limb-threatening ischemia after below-the-knee vascular therapy. https://clinicaltrials.eu/trial/a-study-comparing-one-month-versus-one-year-of-aspirin-and-clopidogrel-treatment-in-patients-with-chronic-limb-threatening-ischemia-after-below-the-knee-vascular-therapy/ Wed, 29 Apr 2026 15:09:17 +0000 https://clinicaltrials.eu/trial/a-study-comparing-one-month-versus-one-year-of-aspirin-and-clopidogrel-treatment-in-patients-with-chronic-limb-threatening-ischemia-after-below-the-knee-vascular-therapy/ This study focuses on patients with Chronic Limb Threatening Ischemia, a severe condition where blood flow to the legs is so poor that it causes pain or tissue damage. The research aims to determine the best length of time to use dual anti-platelet therapy, which is a combination of two medications used to prevent blood clots, following a procedure to improve blood flow in the lower legs. All participants in the study will also take rivaroxaban as part of their standard care.

Participants will be assigned to receive different treatment plans. One group will take aspirin and clopidogrel for one year, while another group will take these same medications for only one month. Some participants may receive a placebo. The study follows these individuals over a period of time to monitor health outcomes related to the leg and overall survival.

]]>